Navigation Links
First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America

In Response, Health Organizations Unite to Help Educate on Good Diabetes Management and How to Reduce the Risk of Other Serious Health Problems

SEATTLE, April 10, 2007 /PRNewswire/ -- A first-of-its-kind report looking at the prevalence and cost of type 2 diabetes complications shows that an estimated three out of five people (57.9 percent) with type 2 diabetes have at least one of the other serious health problems commonly associated with the disease, and that these health problems are taking a heavy financial toll on the United States. In 2006, the nation spent an estimated $22.9 billion on direct medical costs related to diabetes complications.*

The new report, titled State of Diabetes Complications in America, also shows that estimated annual healthcare costs for a person with type 2 diabetes complications are about three times higher than that of the average American without diagnosed diabetes. These complications, which can include heart disease, stroke, eye damage, chronic kidney disease and foot problems that can lead to amputations, cost a person with type 2 diabetes almost $10,000 each year.* People with diabetes complications pay nearly $1,600 out of their own pockets for costs that are not reimbursed by insurance, such as co-payments and deductibles.* This amount is significant, considering that according to the National Health Interview Survey, an estimated 40 percent of adults with diabetes reported a family income of less than $35,000 per year in 2005.

Results from the report were released today at the American Association of Clinical Endocrinologists' (AACE) 16th Annual Meeting and Clinical Congress, by AACE in partnership with the members of a diabetes complications consortium: the Amputee Coalition of America, Mended Hearts, the National Federation of the Blind and the National Kidney Foundation, and supported by GlaxoSmithKline.

* Cost estimates in this report were adjust
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
2. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
3. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
5. Research Results on FluMist Presented at National Association of Pediatric Nurse Practitioners Conference
6. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
7. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
8. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis

Post Your Comments:
(Date:11/27/2009)...INGTON, Minn, Nov. 27 ACUO TECHNOL...e management software, data migration tools and se...tes Patent and Trademark Office has approved a pat... within a Computer Network." Acuo Technologies is ... intellectual property. In general, the granted pa...
(Date:11/26/2009)...JOHANNESBURG, South Africa, Nov. 26 /PRNewswire/ -...ny of the Year Award in the Generic Pharmaceutical...Limited. ,, (Logo: http://www.newscom.com/cgi-...f the Year Award, the following criteria were used...ey competitors: growth strategy and implementation...
(Date:11/25/2009)...WESTON, Fla., Nov. 25 ...SFX) ("the Company") is pleased to announce that t...n management office in Shanghai, China. ,, ASR ...ng an essential gateway for the development and pr...roducts for children and adults to be distributed ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 1Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 2Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences 5693 1Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences 5693 2
...r 11- and 12-year-olds from,meningitis, whooping c...ATLANTA, Aug 28 The Centers for Disease,Control a...tion and,Respiratory Diseases today announced that... the parents of pre-teens are now available to bro...ts, part of CDC,s Pre-Teen,Vaccine campaign, urge ...
...: ICLL) today,announced that its collaborator Merc...ial of V710, an investigational vaccine for the pr...ctions. This randomized double blind,placebo contr...genicity of,the vaccine candidate in patients with...ial start follows the initiation of a separate Pha...
Other Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3
(Date:11/29/2009)... treatment equals a $41,000 pay raise, researchers...ws) -- Psychological therapy may be much more effe...or winning a lottery prize, suggests an English st...f people who provided information about their ment...ness from a $1,329 course of therapy was so signif...
(Date:11/29/2009)...he YogaForce A-Line Athletic Mat is great. It,s a...., author and physician best known for establishin...ne. Go to www.yogaforce.com and order the new M... , San Francisco, CA (PRWE...ays, the YogaForce newly patented, revolutionary A...
(Date:11/28/2009)...RNewswire/ -- Welcome to syngo® .plaza(... routine from Siemens Healthcare. As the first...CS) from Siemens where 2D, 3D, and 4D reading co...sed to change the way multimodality images are rea... the 95th Scientific Assembly and Annual Meeting o...
(Date:11/28/2009)... to consider change after 30-minute psychosocial i.... 27 (HealthDay News) -- A program that gets persi...op their dangerous behavior may lead to significan.... , The new study included 184 men and women wi... who were randomly assigned to one of two interven...
(Date:11/28/2009)...pirits, recognize signs of depression , ,...eniors, the holiday season can trigger melancholy ... health issues or worry about money problems, acco...help overcome the seasonal blues, the AGS Foundati...: , Get out and socialize or invite family and f...
Breaking Medicine News(10 mins):Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Seniors May Need Help Overcoming Holiday Blues 2
...ass., Jan. 15 No one who survives life-threatenin...rson who entered. In her new memoir, "It Gets Bett...orhouse.com ), Maria Machado Munroe draws together... prose she creates an inspirational recounting for...
...n. 15 Kim Alexis is a supermodel, athlete, mother... the Look," where women compete to be the world,s ...Multimedia News Release, go to: http://www.prnews...of energy for no apparent reason, she grew concern...
...ina, Jan. 15 /PRNewswire-Asia-FirstCall/ -- China ..."the Company") (Nasdaq: CSKI ), a,leading fully ...he-counter drugs in the People,s Republic of China...ucts in China since they address common everyday a...
..., Jan. 15 It,s no wonder that millions of America...an Podiatric Medical Association (APMA) estimates ... 75,000 miles on their feet. For many, the pain i...he most common foot problems are ,hammertoes:, a b...
...Jan. 15 Today marked the launch of the National B...ww.nabita.org ). , , NaBITA,s mission: The Nati...ITA) is committed to providing education, developm...vention and intervention. , , NaBITA is a state-...
...IS, Jan. 15 Eli Lilly and Company,(NYSE: LLY ) ...h the United,States Attorney for the Eastern Distr...mer Litigation of the Department of Justice regard...,Zyprexa(R) (olanzapine). , Lilly has been coo...
Other Medicine News:Health News:Cancer as a Crucible: The Story of a Teenage Immigrant Who Survived Cancer and Built a New Life for Herself 2Health News:Cancer as a Crucible: The Story of a Teenage Immigrant Who Survived Cancer and Built a New Life for Herself 3Health News:Video: Supermodel Kim Alexis Joins Forces with the American Association of Clinical Endocrinologists in a National PSA to Raise Awareness About Thyroid Problems 2Health News:China Sky One Medical, Inc. Provides Business Update 2Health News:China Sky One Medical, Inc. Provides Business Update 3Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 2Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 3Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 4Health News:Preventing the Next Virginia Tech -- The National Behavioral Intervention Team Association Launched Today 2Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 2Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 3Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 4Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 5Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 6Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 7
Silicone Sleeve (270 Style)
Meridional Implant (103 Style)
Double Tantalum Clip
Ryan Silicone Strip
Medicine Products: